Midterm Clinical Outcomes of Robotic-Assisted Reverse Hybrid Coronary Revascularization: A Single-Center Experience

Outcomes of robotic-assisted reverse hybrid coronary revascularization (HCR) remain hindered. We aimed to analyze midterm clinical outcomes of robotic-assisted reverse HCR. All consecutive 285 patients who underwent reverse robotic-assisted HCR between September 2005 and July 2021 were included. Reverse HCR comprises percutaneous coronary intervention with stent implantation in non –left anterior descending (LAD) coronary arteries was performed within 30 days before robotic-assisted left internal thoracic artery (LITA) harvesting and LITA-to-LAD manual anastomosis through a 4-cm left minithoracotomy. Dual antiplatelet therapy was not interrupted in any patient.

Source: The American Journal of Cardiology - January 22, 2024 Category: Cardiology Authors: Aleksander Dokollari, Marco Gemelli, Serge Sicouri, William A. Gray, Timothy A. Shapiro, Frank McGeehin, Marwan Badri, Paul Coady, Eric Gnall, Mara Caroline, Amid A. Khan, Massimo Bonacchi, Francesco Cabrucci, Beatrice Bacchi, Bruno Chiarello, Ashish Shah Source Type: research